Dolby Laboratories Inc
NYSE:DLB

Watchlist Manager
Dolby Laboratories Inc Logo
Dolby Laboratories Inc
NYSE:DLB
Watchlist
Price: 80.25 USD -2.11% Market Closed
Market Cap: 7.7B USD
Have any thoughts about
Dolby Laboratories Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Dolby Laboratories Inc

Current Assets 1.5B
Cash & Short-Term Investments 869m
Receivables 476.6m
Other Current Assets 123.1m
Non-Current Assets 1.5B
Long-Term Investments 117.9m
PP&E 517.5m
Intangibles 553.1m
Other Non-Current Assets 316.4m
Current Liabilities 354.5m
Accounts Payable 16.4m
Accrued Liabilities 165.8m
Other Current Liabilities 172.3m
Non-Current Liabilities 186.2m
Other Non-Current Liabilities 186.2m

Balance Sheet
Dolby Laboratories Inc

Rotate your device to view
Balance Sheet
Currency: USD
Sep-2014 Sep-2015 Sep-2016 Sep-2017 Sep-2018 Sep-2019 Sep-2020 Sep-2021 Sep-2022 Sep-2023
Assets
Cash & Cash Equivalents
569
532
516
627
918
797
1 072
1 225
620
745
Cash Equivalents
569
532
516
627
918
797
1 072
1 225
620
745
Short-Term Investments
231
139
122
248
178
119
47
39
189
139
Total Receivables
90
112
77
76
335
386
342
415
420
444
Accounts Receivables
86
102
76
74
332
385
342
415
420
444
Other Receivables
4
11
1
2
2
1
0
0
0
0
Inventory
9
14
16
25
26
32
26
11
24
36
Other Current Assets
107
24
29
35
40
47
61
70
58
123
Total Current Assets
1 006
821
760
1 011
1 497
1 382
1 547
1 761
1 311
1 488
PP&E Net
290
403
444
485
514
537
619
602
560
522
PP&E Gross
290
403
444
485
514
537
619
602
560
522
Accumulated Depreciation
171
202
251
305
362
417
476
538
558
577
Intangible Assets
64
128
215
190
184
181
152
123
112
167
Goodwill
278
308
310
311
328
335
337
341
365
408
Long-Term Investments
296
321
394
314
188
180
52
63
103
98
Other Long-Term Assets
51
153
188
222
155
208
210
217
239
297
Other Assets
278
308
310
311
328
335
337
341
365
408
Total Assets
1 984
N/A
2 133
+8%
2 310
+8%
2 534
+10%
2 865
+13%
2 822
-2%
2 917
+3%
3 106
+6%
2 690
-13%
2 980
+11%
Liabilities
Accounts Payable
16
21
18
14
22
15
13
18
14
21
Accrued Liabilities
115
129
135
158
174
209
175
205
180
215
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
59
60
61
74
89
82
79
93
83
187
Total Current Liabilities
189
210
213
246
285
307
267
316
278
422
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Minority Interest
22
9
9
7
7
6
6
6
5
17
Other Liabilities
63
108
118
144
210
202
212
186
161
185
Total Liabilities
274
N/A
326
+19%
340
+4%
397
+17%
502
+26%
514
+3%
485
-6%
508
+5%
443
-13%
625
+41%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
1 661
1 801
1 938
2 083
2 314
2 328
2 443
2 608
2 298
2 392
Additional Paid In Capital
46
18
42
61
66
0
0
0
0
0
Unrealized Security Profit/Loss
1
0
1
0
3
2
1
0
6
3
Other Equity
3
12
11
7
13
23
11
10
46
34
Total Equity
1 710
N/A
1 807
+6%
1 970
+9%
2 137
+8%
2 364
+11%
2 307
-2%
2 433
+5%
2 598
+7%
2 246
-14%
2 355
+5%
Total Liabilities & Equity
1 984
N/A
2 133
+8%
2 310
+8%
2 534
+10%
2 865
+13%
2 822
-2%
2 917
+3%
3 106
+6%
2 690
-13%
2 980
+11%
Shares Outstanding
Common Shares Outstanding
102
101
101
102
103
100
100
101
96
96

See Also

Discover More